CO
Cardiff Oncology Inc
🇺🇸XNAS.CRDFUnited StatesHealthcare
$1.36USDup +0.01 (+0.74%)OpenDelayed3:37 PM
Price$1.36+0.01 (+0.74%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US14147L1089
- CUSIP
- 98410V109
Company
- Employees
- 30
- Headquarters
- San Diego, United States
- CEO
- Dr. Mani Mohindru Ph.D.
Market
- Shares outstanding
- 77.8M
- Market cap
- $105.8M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $105.02M
- EPS LTM
- -$0.59
- P/E LTM
- -2.20
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $508K-6.96%down year on year
- Net income
- -$40.05M+21.5%up year on year
- Gross margin
- 12.6%+100.33%up year on year
- Free cash flow
- -$40.92M+2.28%up year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.